1-3 of 3
Sebastiano Filetti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump

Free
Ohad Cohen, Sebastiano Filetti, Javier Castañeda, Marianna Maranghi, Mariela Glandt
Journal: Diabetes Care
Diabetes Care 2016;39(Supplement_2):S180–S186
https://doi.org/10.2337/dcS15-3029
Published: 16 July 2016
View article titled, When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump
Open the PDF for When Intensive Insulin Therapy (MDI) Fails in Patients With Type 2 Diabetes: Switching to GLP-1 Receptor Agonist Versus Insulin Pump in another window
Journal Articles

Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A randomized, open-label trial

Open Access
Richard E. Pratley, MD, Michael A. Nauck, MD, Timothy Bailey, MD, Eduard Montanya, MD, Sebastiano Filetti, MD, Alan J. Garber, MD, Anne B. Thomsen, MD, Sabina Furber, MD, Melanie Davies, MD, for the 1860-LIRA-DPP-4 Study Group
Journal: Diabetes Care
Diabetes Care 2012;35(10):1986–1993
https://doi.org/10.2337/dc11-2113
Published: 11 September 2012
View article titled, Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A randomized, open-label trial
Open the PDF for Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes: A randomized, open-label trial in another window
Includes: Supplementary data
Journal Articles

Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes

Open Access
Alessandra Gatti, MD, Marianna Maranghi, MD, Simonetta Bacci, MD, Claudio Carallo, MD, Agostino Gnasso, MD, Elisabetta Mandosi, MD, Mara Fallarino, MD, Susanna Morano, MD, Vincenzo Trischitta, MD, Sebastiano Filetti, MD
Journal: Diabetes Care
Diabetes Care 2009;32(8):1550–1552
https://doi.org/10.2337/dc09-0256
Published: 01 June 2009
View article titled, Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes
Open the PDF for Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes in another window
Includes: Supplementary data